Prognostic Value of Right Atrial Function in Patients with Significant Tricuspid Regurgitation
ESC Heart Failure · 01.12.2024 · 11 (6) · 4019-4027
DOI: 10.1002/ehf2.14846 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 02.08.2024. Verfasst von Takahiro Nishihara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Echocardiography, Heart Atria, Atrial Function, Right. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
Although right ventricular (RV) dysfunction is associated with adverse outcomes in tricuspid regurgitation (TR), the potential role of right atrial (RA) function is unknown. We aimed to investigate the relationship between RA function and clinical outcomes in patients with significant TR.
Methods
This retrospective study included 169 outpatients with moderate or severe TR due to left-sided heart diseases who underwent transthoracic echocardiography between June 2020 and April 2023 (average age, 75 ± 10 years; male, 40%). Patients with atrial fibrillation were excluded from this study due to the inaccuracy of the evaluation using 2D speckle-tracking echocardiography. RA function was compared between patients with and without events, which were defined as all-cause mortality or hospitalization due to heart failure. RA function was calculated as RA global longitudinal strain (RAGLS) with the 2D speckle-tracking echocardiography.
Results
During a median follow-up of 13 months, 19 patients had events (all-cause mortality: 14 cases, hospitalization due to heart failure: 5 cases). RAGLS was lower in patients with events than in those without events (13% ± 10% vs. 18% ± 9%, P = 0.02). When the patients were categorized into two groups [low RAGLS ≤ 16.2% vs. high RAGLS > 16.2%, high RA volume index (RAVI) ≥ 50 mL/m2 vs. low RAVI < 50 mL/m2], Kaplan–Meier curves showed that patients with low RAGLS had higher event rates than those with high RAGLS (log-rank test, P = 0.003). Patients with high RAVI had higher event rates than those with low RAVI (log-rank test, P < 0.001). In the multivariate Cox regression analysis, low RAGLS (≤16.2%) was significantly associated with events in a model that included RV dysfunction (RV fractional area change ≤ 35%) or high RAVI (≥50 mL/m2) (hazard ratio: 4.55, 95% confidence interval: 1.51–13.71, P < 0.01; hazard ratio: 4.57, 95% confidence interval: 1.52–13.79, P < 0.01, respectively).
Conclusions
RAGLS is associated with all-cause mortality and hospitalization due to heart failure in patients with significant TR. Our results suggest that RA function is a sensitive marker for identifying the risk stratification of significant TR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
ORCID-Profile: Takahiro Nishihara
Zitieren
APA
Nishihara, T., Takaya, Y., Nakayama, R., Yoshida, Y., Toh, N., Miyoshi, T., Nakamura, K., & Yuasa, S. (2024). Prognostic Value of Right Atrial Function in Patients with Significant Tricuspid Regurgitation. ESC Heart Failure, 11(6), 4019-4027. https://doi.org/10.1002/ehf2.14846
Vancouver
Nishihara T, Takaya Y, Nakayama R, Yoshida Y, Toh N, Miyoshi T, et al. Prognostic Value of Right Atrial Function in Patients with Significant Tricuspid Regurgitation. ESC Heart Failure. 2024;11(6):4019-4027. doi:10.1002/ehf2.14846
BibTeX
@article{Nishihara2024,
author = {Nishihara, Takahiro and Takaya, Yoichi and Nakayama, Rie and Yoshida, Yu and Toh, Norihisa and Miyoshi, Toru and Nakamura, Kazufumi and Yuasa, Shinsuke},
title = {Prognostic Value of Right Atrial Function in Patients with Significant Tricuspid Regurgitation},
journal = {ESC Heart Failure},
year = {2024},
volume = {11},
number = {6},
pages = {4019--4027},
doi = {10.1002/ehf2.14846}
}
EUVIMED